NCT00270686

Studies of Heritable Disorders of Connective Tissue

Completed Last updated 5 April 2018

What this trial tests

trial in Ehlers-Danlos Syndrome in 929 participants. Completed in 2 January 2015.

Timeline

21 January 2003

2 January 2015

Quick facts

Lead sponsor	National Institute on Aging (NIA)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	929
Start date	21 January 2003
Estimated completion	2 January 2015
Sites	1 location across United States

Conditions studied

• Ehlers-Danlos Syndrome — all drugs for Ehlers-Danlos Syndrome →
• Stickler Syndrome — all drugs for Stickler Syndrome →
• Marfan Syndrome — all drugs for Marfan Syndrome →

Sponsor

National Institute on Aging (NIA)

Who can join

2 and older, any sex, with Ehlers-Danlos Syndrome or Stickler Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background:

\- Heritable disorders of connective tissue are genetic conditions that can affect the skin and other parts of the body. They are related to mutations in genes that are responsible for building tissues. The symptoms differ among disorders. Researchers want to study which genes may be responsible for different disorders. They will be performing a long-term (up to 10 years) study and a study that requires a single visit. These studies will look at how these disorders affect the body and what genes may cause these conditions.

Objectives:

\- To perform one-time and long-term studies of people who have heritable disorders of connective tissue.

Eligibility:

\- Individuals at least 2 years of age who have or may have a heritable disorder of connective tissue.

Design:

* Participants will be screened with a physical exam, medical history, and blood samples.
* Participants will be on one of two parts of this study. The longitudinal arm will require long-term study over about 10 years. The mutational analysis arm will involve a single visit.
* Longitudinal arm participants must be at least 12 years of age. They will have study visits at regular intervals for up to 10 years. The tests given at these visits may include all or some of the following:
* Blood, saliva, urine, and skin samples
* Heart and lung function tests
* Magnetic resonance imaging scans of the neck, chest, spine, and abdomen
* Other imaging studies such as x-rays, bone density scans, and ultrasounds
* Questionnaires about sleep, pain, and quality of life
* Photographs of affected areas.
* Mutational analysis arm participants will have a single study visit. They will provide blood and saliva samples. They will provide tissue from a skin biopsy. They will also let the researchers take photos of any affected body parts. They will complete questionnaires about sleep, pain, and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
   Shalhub S, Black JH, Cecchi AC, Xu Z, et al · · 2014 · cited 97× · PMID 24650746 · DOI 10.1016/j.jvs.2014.01.070